Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study

Bibliographic Details
Title: Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study
Authors: Boothman, Anne-Marie, Scott, Marietta, Ratcliffe, Marianne, Whiteley, Jessica, Dennis, Phillip A., Wadsworth, Catherine, Sharpe, Alan, Rizvi, Naiyer A., Garassino, Marina Chiara, Walker, Jill
Source: In Journal of Thoracic Oncology August 2019 14(8):1390-1399
Database: ScienceDirect
More Details
ISSN:15560864
DOI:10.1016/j.jtho.2019.04.025
Published in:Journal of Thoracic Oncology
Language:English